“…Accessed March 13, 2017). Furthermore, ponazuril, an oxidized toltrazuril metabolite (toltrazuril sulfone), was investigated for antiprotozoal activity in horses, dogs, and cats (Altreuther, Gasda, Schroeder, et al., ; Furr, Quance, & Kennedy, ; Petry, Kruedewagen, Kampkoetter, & Krieger, ). Ponazuril (Marquis ® , Bayer Animal Health) and diclazuril (Protazil ® , Merck Animal Health) are currently indicated for use in horses for the treatment of equine protozoal myeloencephalitis (EPM).…”